Scientists are screening vast libraries of drugs originally developed for conditions other than cancer to detect unrecognized cytotoxic or tumor-suppressing effects. This process involves high-throughput screening and detailed mechanistic studies to understand how these agents interfere with cancer pathways. Such discoveries can quickly lead to clinical trials, as the drugs' human tol... https://www.beatcancerfoundation.org/